Sign in
BIIB Stock Price, Chart, Stats & News
Biogen Inc.
Save
Biogen Inc. (BIIB) does not currently pay a dividend.
20.84B
Market cap
11.19x
Current P/E
–
Forward P/E
BIIB chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - General
Industry
Biogen Inc. is a pioneering biotechnology firm dedicated to the research, development, manufacturing, and distribution of innovative therapies for neurological and neurodegenerative conditions. Its current product portfolio includes a suite of treatments for multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy, Biogen provides SPINRAZA, and it markets FUMADERM for the management of plaque psoriasis.
Similar securities
Based on sector and market capitalization
Report issue